Mode
Text Size
Log in / Sign up

Remote coaching system reduces HbA1c more than usual care in type 2 diabetes at 26 weeks

Remote coaching system reduces HbA1c more than usual care in type 2 diabetes at 26 weeks
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider remote coaching systems may modestly lower HbA1c short-term, but evidence on patient experience and safety is lacking.

A multicenter randomized controlled trial evaluated a 52-week diabetes management system (DMS) with remote coaching versus usual care by a diabetologist in 114 adults with type 2 diabetes (mean age 58, mean baseline HbA1c 8.3%). At the 26-week follow-up, 90 participants completed the study. The primary outcome was change in HbA1c.

The intervention group achieved a significantly greater reduction in HbA1c (-0.9% ± 1.0%) compared to the control group (-0.5% ± 1.0%), with a p-value of 0.044. No significant differences were observed in secondary outcomes, including health-related quality of life (SF-12) and diabetes-related problems (PAID). Among the 43 participants who used the DMS, 32 completed a usability questionnaire, yielding an average System Usability Scale score of 55.4 ± 27.9.

Safety and tolerability data were not reported. Key limitations include the small sample size (90 completers), short 26-week follow-up for a chronic condition, and lack of data on long-term outcomes, safety, or adverse events. The usability score falls below the typical threshold for 'acceptable' systems. Funding and conflicts of interest were not reported.

While the RCT design supports a causal link for the HbA1c benefit, the results are from a single, modest-sized trial. The intervention did not improve patient-reported outcomes. Clinicians should interpret these findings cautiously, awaiting larger studies with longer follow-up and comprehensive safety reporting before considering broader implementation.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up6.0 mo
PublishedApr 2026
View Original Abstract ↓
AIMS: Integrating a diabetes management system (DMS) and personal coaching in patient care may reduce the burden of type 2 diabetes (T2DM) on patients and help address the multifaceted challenges associated with diabetes management. This study aims to assess the impact of the DMS with online coaching in patients with T2DM on changes in HbA1c levels, quality of life, and usability over 26 weeks. MATERIALS AND METHODS: In a multicentre, randomised, controlled trial, adults with T2DM were randomised 1:1 to either 52 weeks of DMS with remote coaching or to usual care by their diabetologist. The DMS enabled a digital diary of blood pressure, blood glucose, and other health parameters, while coaching sessions included structured assessments of individual patient needs. The primary endpoint was changes in the HbA1c level from baseline to 26 weeks. Secondary endpoints included health-related quality of life (SF-12), diabetes-related problems (PAID), and DMS usability (System Usability Scale) at 26-week follow-up. RESULTS: One hundred and fourteen participants (49 females, 58 ± 11 years old [mean ± standard deviation], HbA1c: 8.3% ± 0.7%, body mass index [BMI]: 35.3 ± 7.9 kg/m, diabetes duration: 13.6 ± 7.7 years) were randomised and completed baseline. Ninety participants (39 female, age: 58 ± 11 years old, HbA1c: 8.3% ± 0.7%, BMI: 35.2 ± 7.6 kg/m, diabetes duration: 14 ± 8 years) completed 26-week follow-up. The HbA1c levels improved significantly in the intervention group in comparison to the control group (-0.9% ± 1.0% vs. -0.5% ± 1.0%, p = 0.044). No significant differences were observed in SF-12 and PAID scores at 26-week follow-up. Thirty-two of forty-three participants who used DMS completed the SUS questionnaire with an average score of 55.4 ± 27.9. CONCLUSIONS: DMS with coaching improved glycaemic control compared to usual care in patients with T2DM at 26-week follow-up.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.